NCT03878524 2024-03-04Serial Measurements of Molecular and Architectural Responses to Therapy (SMMART) PRIME TrialOHSU Knight Cancer InstitutePhase 1 Terminated2 enrolled
NCT01445080 2021-02-02Sorafenib in Treating Young Patients With Relapsed or Refractory Solid Tumors or LeukemiaNational Cancer Institute (NCI)Phase 1/2 Completed70 enrolled 26 charts
NCT00217646 2015-04-28Sorafenib in Treating Patients With Refractory or Relapsed Acute Leukemia, Myelodysplastic Syndromes, or Blastic Phase Chronic Myelogenous LeukemiaNational Cancer Institute (NCI)Phase 1 Completed36 enrolled
NCT01159301 2013-09-19Entinostat and Sorafenib Tosylate in Treating Patients With Advanced or Metastatic Solid Tumors or Refractory or Relapsed Acute Myeloid LeukemiaNational Cancer Institute (NCI)Phase 1 Terminated44 enrolled